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ABSTRACT 
We previously established a bovine intestinal epithelial cell line (BIE cells) and showed that BIE cells are useful in vitro 
model system for the study of interactions between pathogenic and beneficial microorganisms and bovine intestinal 
epithelial cells (IECs). In the present study, we aimed to select potential immunomodulatory bifidobacteria that may be 
used to beneficially modulate the inflammatory response in bovine IECs. We also aimed to gain insight into the mo- 
lecular mechanisms involved in the anti-inflammatory effect of bifidobacteria by evaluating the role of Toll-like recep-
tor (TLR)-2 and TLR negative regulators in the regulation of proinflammatory cytokines production and MAPK, NF-κB 
and PI3K pathways activation in BIE cells. Five bifidobacteria strains were evaluated in this study and according to 
their capacity to modulate the inflammatory response of BIE cells. Despite the unique effect of each strain, four common 
points were found when comparing the effect of the high and moderate anti-inflammatory strains: 1) Upregulation of 
TLR negative regulators and the intensity of that upregulation was related to the different immunomodulatory capacity 
of each bifidobacteria strain; 2) The balance between MAPK activation and MKP-1 upregulation affected the anti-in- 
flammatory effect of bifidobacteria in BIE cells; 3) The inhibition of PI3K pathway was related to the anti-inflamma- 
tory effect of bifidobacteria; 4) The immunoregulatory effect of bifidobacteria in BIE cells is partially dependent on 
TLR2. This study shows that BIE cells can be used for the selection of immunoregulatory bifidobacteria and for study-
ing the mechanisms involved in the protective activity of immunobiotics against TLR4-induced inflammatory damage. 
In addition, we have demonstrated that the anti-inflammatory effect of bifidobacteria was achieved by a complex inter-
action of multiple TLRs negative regulators as well as the inhibition/activation of multiple signaling pathways. 
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1. Introduction 
Today, bifidobacteria are economically important be-
cause they are added in high numbers as live bacteria to 
numerous food preparations, with various health-related 
claims, especially those related to the beneficial modula-
tion of the intestinal immune system to avoid unproduc-
tive inflammation [1-4]. In this sense, it was reported that 
Bifidobacterium animalis MB5 protect intestinal Caco-2 
cells from the inflammation-associated response caused 
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by enterotoxigenic Escherichia coli (ETEC) K88 by partly 
reducing pathogen adhesion and by counteracting neu- 
trophil migration [1,2]. In addition, experiments in Caco- 
2 cells showed that B. animalis MB5 counteracts ETEC- 
induced upregulation of interleukin (IL)-1β and tumor 
necrosis factor α (TNF-α), and the downregulation of 
transforming growth factor β1 (TGF-β1) expression, and 
consequently to block the cytokine deregulation [1,2]. 
Others studies evaluating the effect of bifidobacteria in 
mice showed that the deliberate consumption of B. ani-
malis AHC7 resulted in the attenuation of nuclear factor 
κB (NF-κB) activation within mice infected with a pro- 
inflammatory translocating microbe, Salmonella typhi-
murium. In addition, B. animalis AHC7 consumption was 
associated with modulation of cytokine signaling within 
the mucosa of healthy animals. In vitro, dendritic cells 
(DCs) bound B. animalis AHC7, secreted IL-10 and IL- 
12p70, and DCs stimulated with B. animalis AHC7 en- 
hanced Foxp3 expression in naïve T cells [5]. In addition, 
Hoarau et al. [6] demonstrated that the supernatant of 
Bifidobacterium breve C50 induces DCs maturation 
through TLR2, with a high IL-10 production. These and 
other studies clearly demonstrate that bifidobacteria are 
highly effective in inducing intestinal tolerance and regu- 
lating unproductive inflammation. 
Because of the beneficial immunoregulatory properties 
of probiotics, there is increasing interest in the use of 
these microorganisms for decreasing incidence of infec- 
tions and ameliorating inflammatory gastrointestinal dis- 
eases in animals. In this sense, several studies have been 
conducted in vivo utilizing different probiotic strains to 
evaluate the effect of immunobiotics against intestinal 
infections and unproductive inflammation, however the 
majority of these studies were performed in swine and 
only a few in the cattle [7,8]. The use of probiotics in 
cattle could be improved by the development of in vitro 
systems specifically for cattle that allow the simple and 
efficient assess of the immunomodulatory activity of the 
potential probiotic strains. 
We have recently established a bovine intestinal epithet- 
lial cell line (BIE cells) [9]. When BIE cells are cultured 
they assume monolayer cobblestone and epithelial-like 
morphology with close contact between the cells. More- 
over, scanning electron microscopy examination of BIE 
cell revealed that 3-days old cells have irregular and 
slender microvilli-like structures on their surface and that 
these structures increase in complexity as the cells grow 
[9]. We have also showed that BIE cells are useful in 
vitro model system for the study of interactions between 
patho- gen-associated molecular patterns (PAMPs) and 
bovine intestinal epithelial cells (IECs) [10]. In fact, our 
findings indicate that BIE cells are useful cell line for 
studying inflammatory responses via Toll-like receptor 
(TLR) activation in vitro. Considering that inflammatory 
responses induced by PAMPs derived from intestinal 
pathogens can lead to dysregulation of IECs signaling, 
disruption of membrane barrier integrity, enhancement of 
pathogen translocation and disease [11], BIE cells can be 
used to evaluate therapies designed for preventing in-
flammatory damage caused by these PAMPs during in-
fections in the gut [10]. 
In the present study, we aimed to select potential im-
munomodulatory bifidobacteria that may be used to bene-
ficially modulate the inflammatory response in bovine 
IECs. Over the past decade it has become clear that pro-
biotic and commensal organisms can interact with IECs 
lining the mucosa to modulate specific functions of the 
mucosal immune system and that interaction involves the 
innate pattern recognition receptors (PRRs) such as TLRs. 
Therefore, we also aimed to gain insight into the molecu- 
lar mechanisms involved in the anti-inflammatory effect 
of bifidobacteria by evaluating the role of TLR2 and TLR 
negative regulators in the regulation of proinflammatory 
cytokines production and mitogen-activated protein kinases 
(MAPK), NF-κB and phosphatidylinositol 3-kinase (PI3K) 
pathways activation in BIE cells. 
2. Materials and Methods 
2.1. BIE Cells 
The bovine intestinal epithelial cell line (BIE cells) was 
originally derived from fetal bovine intestinal epithelio-
cytes, and then established as a SV40 large T antigen- 
transformed intestinal cell line as previously described 
[9]. BIE cells were maintained in Dulbecco’s modified 
Eagle medium (DMEM; GIBCO, Grand Island, NY) con-
taining 10% heat-inactivated fetal bovine serum (FBS) 
and penicillin-streptomycin until it they were used for 
further studies. For the passage, BIE cells were treated 
with a sucrose/EDTA buffer (0.1 M Na2HPO4/12H2O, 
0.45 M Sucrose, 0.36% EDTA/4Na, BSA) for 4 min, 
detached using 0.04% trypsin in phosphate-buffered sa-
line (PBS, pH 7.2). Then, BIE cells were plated in colla-
gen type I-coated culture dishes (Sumilon, Tokyo, Japan) 
at 1.5 × 104 cells/cm2 and cultured at 37˚C in an atmos-
phere of 5% CO2 in Dulbecco’s Modified Eagle media 
(DMEM) (10% FCS, 1% streptomycin/penicillin, 100 
U/ml streptomycin, high glucose, L-glutamine, 0.11 mg/ml 
sodium pyruvate; GIBCO). 
2.2. Microorganisms 
Bifidobacteria were provided by Morinaga Milk Industry 
Co. Ltd. (Zama, Japan). Five different strains were used 
in the experiments: B. longum BB536, B. adolescentis 
ATCC15705, B. adolescentis MCC-75, B. breve MCC- 
117 and B. infantis MCC-1021 [12]. 
Bifidobacteria were grown in Man-Rogosa-Sharpe broth  
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and agar (Difco, Detroit, MI, USA) supplemented with 
0.05% (w/v) cysteine (Sigma, Tokyo, Japan), and incu- 
bated at 37˚C for 16 h under anerobic conditions (An- 
aeroGen; Oxoid, Basingstoke, UK). Cultures were then 
centrifuged at 3000 rpm for 10 minutes and bifidobacte- 
ria were washed with PBS, and heat killed (60˚C, 30 min). 
These bacterial samples were resuspended in DMEM, 
enumerated using a Petroff-Hausser counting chamber, 
and stored at −80˚C until use. 
Enterotoxigenic Escherichia coli (ETEC) strain 987 
(O9: H−: 987P+: STa+) was kindly provided by Dr. M. 
Nakazawa, National Institute of Animal Health (Tsukuba, 
Japan) [13,14]. ETEC cells were grown in blood agar 
(5% sheep blood) for 2 hours at 37˚C and then trans- 
ferred to tryptic soy broth (TSB; Becton, Dickinson and 
Company, USA) for 5 days at 37˚C without shaking. 
ETEC cell were collected and transferred to 1L TSB and 
cultured 20 hours at 37˚C with shaking. After incubation, 
the subcultures of bacteria were centrifuged at 5000 × g 
for 10 min at 4˚C and washed with PBS (pH 7.2). Finally, 
ETEC cell were heat killed at 100˚C for 15 minutes and 
then washed with PBS. Heat-killed ETEC were sus- 
pended in DMEM for use. 
2.3. Anti-Inflammatory Assay in BIE Cells 
Bifidobacteria were re-suspended in DMEM (10% FSC, 
1% SP), enumerated in a microscope using a Petroff- 
Hausser counting chamber, and stored at –80˚C until use. 
BIE cells were plated at 3 × 104 cells/well of a 12-well 
ptype I collagen-coated plates (Iwaki, Tokyo, Japan), and 
cultured for three days. After changing medium, bifido- 
bacteria (5 × 107 cells/ml) were added and 48 hours later, 
each well was washed vigorously with medium at least 3 
times to eliminate all the stimulants. BIE cells were 
treated with heat-killed ETEC (final concentration: 5 × 
107 cells/ml) for indicated time and the expression of 
cytokines, chemokines and TLRs negative regulators 
were studied by using real time PCR as de scribed below. 
In addition, activation of p38, c-Jun N-terminal kinase 
(JNK) and extracellular signal-regulated kinase (ERK) 
MAPKs, PI3K and NF-kB pathways were studied by 
using western blotting as described below. In some ex- 
periments, the synthetic TLR2 agonist tripalmitoylated 
lipopeptide Pam3CysSerLys4 (Pam3CSK4) was also 
used. BIE cells were stimulated with Pam3CSK4 (final 
concentration: 200 ng/ml) for the indicated time same as 
the other stimuli. 
In blocking experiments, unlabeled anti-human TLR2- 
mouse IgG (Clone #TL2.1, Cat. #309710, Biolegend, San 
Diego, CA) and its isotype control antibody (MOPC-173, 
Cat. #400224, Biolegend) was used. Cultured PIE cells 
were incubated with the unlabeled anti-TLR2 or isotype 
control antibody for 12 h before stimulation with bacteria. 
2.4. Quantitative Expression Analysis by PCR in 
BIE Cells 
Two-step real-time quantitative PCR was used to char- 
acterize the expression of cytokines, chemokines and 
TLRs negative regulators mRNAs in BIE cells. Total 
RNA from each sample was isolated from the BIE cells 
using TRIzol reagent (Invitrogen). All cDNAs were syn- 
thesized from 5 μg of total RNA using a Quantitect Re- 
verse Transcription kit (Qiagen, Tokyo, Japan) according 
to the manufacturer’s recommendations. Real-time quan- 
titative PCR was carried out using a 7300 Real-time PCR 
System (Applied Biosystems, Warrington, UK) using 
Platinum SYBR Green qPCR SuperMix UDG with ROX 
(Invitrogen). The primers for cytokines, chemokines and 
TLRs negative regulators used in this study are described 
in Table 1. The PCR cycling conditions were 5 min at 
50˚C; followed by 5 min at 95˚C; then 40 cycles of 15 
sec at 95˚C, 30 sec at 60˚C and 30 sec at 72˚C. The reac- 
tion mixture contained 5 μl of the sample cDNA and 15 
μl of the master mix including the sense and antisense 
primers. Expression of β-actin was used to normalize 
cDNA levels for differences in total cDNA levels in the 
samples. TLRs mRNA levels in BIE cells were calibrated 
by the bovine β-actin level, and normalized by common 
logarithmic transformation in comparison to the each 
control (as 1.00). 
 
Table 1. Primer sequences used in this study. 
Primer Sense primer Antisense primer Accession number
β-actin TGG ATT GGC GGC TCC AT GCT GAT CCA CAT CTG CTG GAA NM_173979 
MCP-1 CAC CAG CAG CAA GTG TCC TAA A CAC ATA ACT CCT TGC CCA GGA T NM_174006 
IL-6 GCC ACA CGT GCT TGA ACA AA CCA TGC GCT TAA TGA GAG CTT NM_173923 
MKP-1 CGCAGCGCGCAAATCT CGGGTAGGAAGCAGAAAAAGC NM_001046452 
IRAK-M ACAGCGGAGCGGCTTTC CTTGGTCTACATATTTTTCAATGTGA NM_001190299 
SIGIRR GGCAGTGAAGTGGATGTGTCA TCCGTGCGGGCACTGTA NM_001082443 
BCL3 CATGGAACACCCCCTGTCA GGCGTATCTCCATCCTCATCA NM_001205993 
Tollip CGGGCGTGGACTCTTTCTAC GATGCGGTCGTCCATGGA NM_001039961 
ABIN-3 CGCAGAACGAATTGCTGAAA CACTACGCTCCCTCTGGAAGTC BC102932 
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2.5. Western Blotting 
BIE cells cultured in 1.8 × 105 cells/60mm dishes were 
simulated with bifidobacteria or Pam3CSK4 with same 
time schedule and equivalent amount as mentioned above. 
BIE cells were then washed and stimulated with heat- 
killed ETEC for indicated time. After stimulation, BIE 
cells were washed three times with PBS and resuspended 
in 200 μl of CelLytic M Cell Lysis Reagent (Sigma-Al- 
drich, St. Louis, MO, USA) including protease and phos- 
phates inhibitors (complete Mini, PhosSTOP: Roche, 
Mannheim, Germany). Protein concentration was meas- 
ured with BCA protein assay kit (Pierce, Rockford, IL, 
USA). Extracts (120 μl) were transferred into Eppendorf 
tubes and were added with 40 μl of Sample Buffer Solu- 
tion (2ME+) (×4) (Wako), and boiled for 5 min at 95˚C. 
Equal amounts of extracted proteins (2 μg) were loaded 
on 10% SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE). Separated proteins were transferred electropho- 
retically to a PVDF membrane. The membrane was 
blocked with 2% BSA/TBS-T (w/v) for 2 hours at room 
temperature. Phosphorylation of PI3K, p38, JNK and ERK 
mitogen-activated protein kinases and nuclear factor 
kappa B inhibitor alpha (IkBα) degradation were evalu- 
ated using Phospho-PI3K p85 (Tyr458)/p55 (Tyr199) 
antibody (p-PI3K, #4228); PI3K kinase p85 antibody 
(PI3K, #4292); Phospho-p38 MAPK (Thr180/Tyr182) 
antibody (p-p38, #9211); p38 MAPK antibody (p38, 
#9212); Phospho-SAPK/JNK (Thr183/Tyr185) antibody 
(p-JNK, #9251); SAPK/JNK antibody (JNK, #9252); 
Phospho-p44/42 MAP kinase (Thr202/Thy204) antibody 
(p-ERK, #9101); p44/42 MAP (Erk 1/2) antibody (ERK, 
#9102); I kappaB-alpha antibody (IkBa, #9242) from 
Cell Signaling Technology (Beverly, MA, USA) at 1000 
times dilution of their original antibodies overnight at 
room temperature. After washing with TBS-T, the mem- 
brane was incubated alkaline phosphatase conjugated 
anti-rabbit IgG (#A3937, Sigma) at 2000 times dilution 
for 1 hour at room temperature. After washing with 
TBS-T, signals were generated by overlaying the mem- 
brane with ECFTM substrate (GE Healthcare, Piscataway, 
NJ, USA) for 5 min at room temperature under dark con- 
ditions. The Attophos (Ex; 440 nm, Em; 560 nm) was 
detected by Molecular Imager Fx (Bio-Rad, Hercules, 
CA, USA). The densitometry of western blots was car- 
ried out by using Image J software. The relative density 
was expressed as the area of the peak in the densitogram, 
in which expressed as 1.0 at 0 min, and compared with 
that of ETEC control at each time point. 
2.6. Statistical Analysis 
Normalized relative expression of each control data 
(showed as the ratio to β-actin mRNA expression) was 
transferred to a normal distribution with a mean of 1.0. In 
order to normalize the control data, they were fitted by  
using the function:     i i x xcontrolZ x x x      , in  
which Z(xi): all adjusted data; xi: ith experimental data,  
x(control): a mean of repeated control data; and σx was a 
standard deviation of repeated control or trial data. Simi- 
larly, normalized relative expression for heat-killed ETEC 
and bifidobacteria data was fitted to this function to show 
them as a fold value compared to the control data. Each 
of data number repeated in a same condition was from 8 
to 10. Statistical analysis was performed by using SAS 
computer program, GLM procedure. The multiple com-
parisons among means of fold expression were carried 
out by Fisher’s least significance differential test, LSD 
method. Differences were significant at 5% level and 
were showed in graphs with superscripts letters. 
3. Results 
3.1. Effect of Bifidobacteria on Heat-Killed 
ETEC-Induced Inflammatory Response in 
BIE Cells 
Our studies showed that TLR4 is expressed at com- 
parably higher level in BIE cells (Takanashi et al., 2013. 
BMC Microbiol, In press), and that challenge of BIE 
cells with heat-killed ETEC significantly increased the 
expression of pro-inflammatory cytokines MCP-1 and 
IL-6 (Figure 1). Then, we first aimed to evaluate if the 
bifidobacteria strain were able to modulate the expres- 
sion of these cytokines in heat-killed ETEC-challenged 
BIE cells. For this reason, BIE cells were stimulated for 
48 hours with each bifidobacteria strain or the synthetic 
TLR2 agonist Pam3CSK4 and then challenged with heat- 


































































Figure 1. Expression of cytokines in BIE cells after stimula-
tion with heat-killed Enterotoxigenic Escherichia coli (ETEC). 
BIE cells were pre-treated with bifidobacteria for 48 h and 
stimulated with heat-killed ETEC. The expression of MCP- 
1 and IL-6 mRNAs were studied at 12 h post-stimulation. 
The results represent four independent experiments. Sig-
nificant differences are showed under the solid line (P < 
0.05). 
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MCP-1 and IL-6 were evaluated (Figure 1). Stimulation 
of BIE cells with all bifidobacteria strains significantly 
decreased the production of IL-6 in response to heat- 
killed ETEC challenge. However, levels of MCP-1 were 
significantly lower than controls only in PIE cells treated 
with B. adolescentis MCC-75 and B. breve MCC-117 
(Figure 1). In addition, we observed that Pam3CSK4 
was able to reduce levels of IL-6 and MCP-1 in PIE cells, 
although the effect was significantly lower when com- 
pared with B. adolescentis MCC-75 and B. breve MCC- 
117 (Figure 1). 
3.2. Effect of Bifidobacteria on MAPK, PI3K 
and NF-κB Pathways in BIE Cells 
We next evaluated whether bifidobacteria were able to 
attenuate heat-killed ETEC-mediated pro-inflammatory 
responses by modulating the NF-κB pathway. Challenge 
of BIE cells with heat-killed ETEC significantly reduced 
the levels of the counter-regulatory factor IκB (Figure 
2A). BIE cells previously stimulated with B. longum 
BB536 or B. infantis MCC-1021 did not show a signifi- 
cant degradation of IκB early from minute 5 after chal- 
lenge, indicating an inhibitory effect in NF-κB pathway 
(Figure 2A). B. adolescentis ATCC15705 and B. ado- 
lescentis MCC-75 were also able to reduce NF-κB path- 
way activation 20 minutes after the challenge, while BIE 
cells treated with B. breve MCC-117 did not show dif- 
ferences when compared with control BIE cells (Figure  
2A). Challenge of BIE cells with heat-killed ETEC sig- 
nificantly increased phosphorylation of PI3K (Figure 
2B). BIE cells previously stimulated with MCC-117 and 
MCC-75 showed significantly lower levels of phosphory- 
lated PI3K on minutes 20 and 40 when compared with 
control BIE cells. On the contrary, BB536, ATCC15705 
and MCC-1021 strains significantly increased levels of 
phosphorylated PI3K, being the effect of ATCC15705 
strain higher than the other strains (Figure 2B). 
We also examined the relationship between MAPK 
activation and regulation of pro-inflammatory cytokines 
in BIE cells by bifidobacteria. BIE cells were stimulated 
with each bifidobacteria strain or control medium and; 
the activation profiles of p38, ERK and JNK were com- 
pared. As shown in Figure 3 heat-killed ETEC induced 
the phosphorylation of p38 and ERK, which reached a 
maximum between 5 and 10 minutes. Pretreatment of 
BIE cells with B. longum BB536 significantly increased 
the levels of phosphorylated p38, JNK and ERK on min- 
utes 5 and 40 (Figure 3). We also observed significantly 
higher levels of phosphorylated p38 in B. adolescentis 
MCC-75-treated BIE cells and higher levels of phos- 
phorylated ERK in BIE cells treated with both MCC-75 
and MCC-117 strains. In addition, B. adolescentis  
ATCC15705 reduced the activation of p38 and JNK 
pathways while B. infantis MCC-1021-tretaetd BIE cells 
showed decreased levels of phosphorylated p38 and and 
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Figure 2. Western blot analysis of NF-κB (A) and PI3K (B) pathways activation on BIE cells after challenge with heat-killed 
ETEC. BIE cells were pre-treated with different bifidobacteria strains for 48 h and stimulated with heat-killed ETEC. Levels 
of the counter-regulatory factor IκBα and phosphorylated PI3K were studied at the indicated times post-stimulation. 
*Indicates significant differences against ETEC control at each time point (P < 0.05). 
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Figure 3. Western blot analysis of activation of p38 (A), JNK (B) and ERK (C) mitogen-activated protein kinases in BIE cells 
after challenge with heat-killed ETEC. BIE cells were pre-treated with different bifidobacteria strains for 48 h and then 
stimulated with heat-killed ETEC. Phosphorylation of p38, JNK, and ERK was studied at the indicated times post-stimula- 
tion. *Indicates significant differences against ETEC control at each time point (P < 0.05). 
 
3.3. Role of TLR2 in the Anti-Inflamamtory  
Activity of Bifidobacteria 
In order to study the role of TLR2 in the immunomodu- 
latory effect of bifidobacteria, we next performed com- 
parative studies with anti-TLR2 blocking antibodies (Fig- 
ure 4). The use of anti-TLR2 antibodies abolished the 
reduction of IL-6 mRNA levels induced by BB536, 
ATCC15705, MCC-75 and MCC-117 strains in heat- 
killed ETEC-challenged BIE cells. In addition, no effect 
was observed in the levels of MCP-1 (Figure 4). 
3.4. Effect of Bifidobacteria on Negative  
Regulators of the TLRs Signaling Pathway 
in BIE Cells 
We studied the negative regulators that are known to 
mediate the TLR signaling pathway. First, we evaluated 
the changes in TLRs negative regulators that regulate the 
activation of several pathways involved in TLR4 signal- 
ing at the same time. We consider the intracellular TLR 
inhibitors Toll interacting protein (Tollip), A20-binding 
inhibitor of nuclear factor kappa B activation 3 (ABIN-3), 
and interleukin-1 receptor-associated kinase M (IRAK-M) 
as well as the TLR membrane-bound suppressor single 
immunoglobulin IL-1-related receptor (SIGIRR) (Figure 
5). We observed a significant reduction of SIGIRR in 
hour 3 after the challenge with ETEC in all groups. BIE 
cells treated with MCC-117 and MCC-1021 restored the 
normal levels of SIGIRR on hours 6 and 12 respectively. 
Differently, BIE cells treated with BB536, ATCC15705 
or MCC-75 showed significantly higher levels of SIGIRR 
after hour 3 post-challenge (Figure 5). All the bifido- 
bacteria strains upregulated the expression of Tollip and 
ABIN-3, however the effect of B. adolescentis MCC-75 
was significantly higher than the other strains (Figure 5). 
In addition, BB536, ATCC15705 and MCC-75 upregu-  
K. MURATA  ET  AL. 




Figure 4. Role of TLR2 in the immunomodulatory effect of bifidobacteria in BIE cells. BIE cells were pre-treated with bifi-
dobacteria strains in the presence or absence of anti-TLR2 antibodies. Untreated BIE cells were used as controls. BIE cells 
were stimulated with heat-killed ETEC, and then the expression of MCP-1 and IL-6 was studied at 12 h post-stimulation. The 
results represent four independent experiments. *Indicates significant differences between presence or absence of anti-TLR2 
antibodies (P < 0.05). 
 
 
Figure 5. Expression of toll-like receptor negative regulators in BIE cells. BIE cells were pre- treated with different bifido-
bacteria strains for 48 h, stimulated with heat-killed ETEC, and the expression of SIGIRR, Tollip, ABIN-3, and IRAK-M 
negative regulators was studied at the indicated time points. The results represent four independent experiments. *Indicates 
significant differences against ETEC control at each time point (P < 0.05). 
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lated the expression of IRAK-M at hour 3 post-ETEC 
challenge, while strains MCC-117 and MCC-1021 did 
not induce changes in the mRNA levels of this TLR 
negative regulator (Figure 5). 
We also studied the effect of bifidobacteria on the ex- 
pression of the NF-κB pathway inhibitor B-cell lym- 
phoma 3-encoded protein (Bcl-3) and the MAPK path- 
way inhibitor mitogen-activated protein kinase 1 (MKP-1) 
(Figure 6). BB536, ATCC15705 and MCC-75 strain 
upregulated the expression of Bcl-3 in ETEC challenged- 
BIE cells, being the effect of B. adolescentis MCC-75 
significantly higher than the other strains (Figure 6). In 
addition, we observed a significant increase of MKP-1 in 
hour 3 after the challenge with heat-killed ETEC in all 
groups. However, the levels of MKP-1 in BB536- and 
ATCC15705-treated BIE cells were significantly higher 
that those observed in the other groups (Figure 6). 
4. Discussion 
The use of probiotics in animal feeding could be en- 
hanced by preliminary in vitro screening such us the po- 
tential to adhere to IECs, production of inhibitory sub- 
stances, survival in the gastrointestinal tract, antibiotic 
susceptibility [15] or immunoregulatory activities in im- 
mune and IECs [12] that can be analyzed to evaluate 
functionality and safety [7]. In this sense, we developed a 
method for evaluating the immune responses to immuno- 
biotic bifidobacteria by constructing a porcine TLR2 
(pTLR2)-expressing transfectant (HEKpTLR2 cells) [16,17]. 
We used the HEKpTLR2 immunoassay system to evaluate 
various bifidobacteria, belonging to different species, on 
the activation pattern of pTLR2-overexpressing cells [12]. 
As it has been observed in studies in which bifidobacteria 
were evaluated using immune cells [18], we observed a 
strain-specific capacity of bifidobacteria to stimulate  
HEKpTLR2 cells. Of the strains tested, B. breve MCC-117 
was the one that showed the highest NF-κB activity in 
the HEKpTLR2 immunoassay system, while other strains 
of the same species were less effective or did not modify 
this parameter [12]. We selected B. breve MCC-117 and 
evaluated its anti-inflammatory effect using co-cultures 
of porcine intestinal epithelial cell line (PIE cells) and 
immune cells from porcine PPs and as well as heat-killed 
ETEC as inflammatory challenge [12]. We demonstrated 
that B. breve MCC-117 treatment was able to signifi- 
cantly reduce the expression of inflammatory cytokines 
in PIE cells in response to heat-killed ETEC. In addition, 
B. breve MCC-117 treatment was able to significantly 
reduce the levels of IFN-γ in both CD4+ and CD8+ lym- 
phocytes and improved IL-10 levels in CD4+CD25high 
Foxp3+ lymphocytes [12]. 
These previous works demonstrated that it would be 
possible to modulate the intestinal immune system of 
animals by using appropriate bifidobacteria strains. So 
far, the majority of the studies evaluating the effect of 
probiotics in live stock animals were performed in swine 
and only few in the cattle [10,15]. Therefore, we were 
interesting in selecting immunoregulatory bifidobacteria 
for their use in cattle. In this work we used a previously 
established a bovine intestinal epithelial cell line (BIE 
cells) and TLR4-mediated inflammatory response to se- 
lect bifidobacteria strains with immunomodulatory ca- 
pacity. TLR4 is conserved among different species and 
its expression appears to be a characteristic feature of 
IECs [19], therefore, the presence of TLR4 in BIE cells 
resembles IECs of other species. In addition, the ETEC 
987P strain used in this study does not express flagellin 
and we have demonstrated that the main molecule re- 
sponsible for the inflammatory response triggered by this 
bacterium is the LPS present on its surface [13,20]. Then, 
 
 
Figure 6. Expression of toll-like receptor negative regulators in BIE cells. BIE cells were pre-treated with different bifidobac-
teria strains for 48 h, stimulated with heat-killed ETEC, and the expression of MKP-1 and Bcl-3 negative regulators was 
studied at the indicated time points. The results represent four independent experiments. *Indicates significant differences 
against ETEC control at each time point (P < 0.05). 
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we showed that heat-killed ETEC significantly enhanced 
the production of IL-6 and MCP-1 in BIE cells by acti- 
vating NF-κB, PI3K and MAPK pathways. Moreover, in 
the present study, we demonstrated for the first time that 
bifidobacteria can modulate the response of bovine intes- 
tinal epithelial cells to TLR4 activation via modulation of 
different signaling pathways. 
Five bifidobacteria strains were evaluated in this study 
and according to their capacity to modulate the produc- 
tion of IL-6 and MCP-1 in ETEC challenged-BIE cells, 
they can be divided in the following two groups: 1) 
strains able to reduce both IL-6 and MCP-1 (B. adoles- 
centis MCC-75 and B. breve MCC-117) and 2) strains 
able to reduce only IL-6 (B. longum BB536, B. adoles- 
centis ATCC15705 and B. infantis MCC-1021). When 
we analyzed the activation of MAPK, NF-κB and PI3K 
pathways in BIE cells we found that each strain induces 
unique changes in TLR4 signaling. Another interesting 
feature of our study relates to the modulation of TLR 
negative regulators by bifidobacteria. When we evaluated 
the effect of the bifidobacteria strains on TLRs negative 
regulators expression in BIE cells we also found strain- 
dependent changes. Despite the unique effect of each 
strain, four general conclusions can be made when com- 
paring the effect of the two different immunoregulatory 
groups: high anti-inflammatory activity (B. adolescentis 
MCC-75) and moderate anti-inflammatory activity (B. 
adolescentis ATCC15705) (Figure 7). 
1) The upregulation of TLR negative regulators and 
the intensity of that upregulation would be related to the 
different immunomodulatory capacity of each bifidobac- 
teria strain. It has been reported that several TLRs nega- 
tive regulators have important roles in the regulation of 
inflammatory responses in IECs. A20 deficiency in en- 
terocytes renders mice sensitive to TNF-α-induced lethal 
inflammation, leading to disruption of the epithelial bar- 
rier and infiltration of commensal bacteria that initiate a 
systemic inflammatory response [21], suggesting that 
 
 
Figure 7. Proposed mechanism for the immunomodulatory effect of Bifidobacterium adolescentis ATCC-15705 and Bifido-
bacterium adolescentis MCC-75 in bovine intestinal epithelial cells. (−) inhibition; (+) stimulation. 
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A20 is important for the inhibition of innate immune 
responses in the gut [22]. ABINs have been described as 
three different proteins (ABIN-1, ABIN-2, ABIN-3) that 
bind A20. Overexpression of ABINs inhibits NF-κB ac- 
tivation by TNF-α and several other stimuli. Similar to 
A20, ABIN-3 expression is NF-κB dependent, implicat- 
ing a potential role for the A20/ABIN complex in the 
negative feedback regulation of NF-κB activation [23]. 
On the other hand, Bcl-3 protein functions as an inhibitor 
of NF-κB activity by stabilizing repressive NF-κB ho- 
modimers in a DNA-bound state and preventing bind- 
ing of dimers that activate transcription. In fact, stabiliza- 
tion of repressive complexes through the induction of 
Bcl-3 expression is proposed to function in the process of 
LPS tolerance [24]. Treatment of macrophages with IL- 
10 induces the expression of Bcl-3, and Bcl-3 expression 
leads to inhibition of LPS-induced TNF-α production 
[25]. In addition, IECs deficient in SIGIRR are more 
susceptible to commensal-dependent intestinal inflame- 
mation indicating the intrinsic expression of SIGIRR by 
IECs regulates the communication between commensal 
bacteria and host immune system [26]. Tollip and IRAK- 
M are also known to be expressed at high levels in IECs, 
and to thereby contribute to the hyporesponsiveness of 
IECs to commensals [27,28]. Therefore, induction of 
these five negative regulators by bifidobacteria in BIE 
cells may be important for establishing tolerance against 
ETEC challenge (Figure 7). Moreover, the fold expres- 
sion increase should be also important since the levels of 
ABIN-3, IRAK-M and Bcl-3 were significantly higher in 
B. adolescentis MCC-75-treated BIE cells when com- 
pared with BIE cells treated with the moderate anti-in- 
flammatory strain B. adolescentis ATCC15705 (Figure 
7). 
2) The balance between MAPK activation and MKP-1 
upregulation would be related to the anti-inflammatory 
effect of bifidobacteria in BIE cells. The MAPK pathway 
is involved in the upregulation of several inflammatory 
genes, such those encoding inducible nitric oxide syn- 
thase, IL-8, and IL-6. In addition, MKP-1 plays a role in 
the inhibition of proinflammatory mRNA expression, 
because it can inactivate MAPK pathway. An MKP-1 
deficiency leads to hyperresponsiveness to LPS stimula- 
tion in innate immune cells [29]. Moreover, MKP-1 de- 
sensitizes enterocytes to TLR ligands by inactivating the 
p38 signaling pathway [30]. Therefore, we expected that 
bifidobacteria with high anti-inflammatory activity sig- 
nificantly upregulate MKP-1 expression and reduce MAPK 
activation. However, when we analyzed ERK, p38 and 
JNK MAPK activation and MKP-1 expression in BIE 
cells treated with bifidobacteria, we found that bifido- 
bacteria with high anti-inflammatory potential activated 
ERK MAPK pathway and only moderately upregulated 
MKP-1 (Figure 7). On the contrary, bifidobacteria strains 
with moderate anti-inflammatory activity such as B. ado- 
lescentis ATCC15705 strongly increased expression of 
MKP-1 and inhibit p38 and JNK pathways (Figure 7). 
The ERK pathway is invoked in various cell types by 
diverse extracellular stimuli. Stimulation of this pathway 
activates a series of protein kinases and finally activates 
ERK1/2, which in turn phosphorylates downstream tar- 
gets involved in cellular events such as cell proliferation, 
differentiation, survival, and motility [31]. It has been 
demonstrated that TGF-β rapidly induces ERK1 activity 
in IECs and that this TGF-β and ERK interaction regu- 
lates gene expression that is crucial for cell growth and 
survival of IECs as well as IECs migration [32,33]. 
Moreover, TGF-β increases protein levels, collagen I, 
TGF-β, of type-1 inhibitor of plasminogen activator and 
the T TGF-β-converting enzyme furin in various IEC 
lines via ERK [34] indicating an important immunoregu- 
latory role of the ERK pathway in maintaining homeo- 
stasis in IECs. Therefore, the activation of the ERK 
pathway by B. adolescentis MCC-75 and B. breve MCC- 
117 during ETEC-mediated inflammation could have an 
important protective role against inflammatory damage. 
3) The inhibition of PI3K pathway would be related to 
the anti-inflammatory effect of bifidobacteria in BIE cells. 
We showed that B. adolescentis MCC-75 and B. breve 
MCC-117, the strains able to significantly reduced ex- 
pression of IL-6 and MCP-1 in BIE cells, were also able 
to inhibit PI3K pathway. The family of PI3K enzymes is 
largely responsible for the phosphorylation of phosphati- 
dylinositol lipids in response to cellular stimuli. PI3K 
regulates TLR signaling in both positive and negative 
ways. It was showed that site-directed mutagenesis of 
specific tyrosine residues within the cytosolic domain of 
TLR2 resulted in a loss in the ability of p85 to associate 
with TLR2 and abrogated the ability of the TLR2 to in- 
duce NF-κB transcriptional activity. Furthermore, inhibi- 
tion of PI3K during TLR2 stimulation, through use of 
either Ly294002 or dominant-negative Akt, has been 
shown to greatly reduce NF-κB activation [35]. Studies 
on PI3K knock out mice; however, support the idea that 
PI3K negatively regulates TLR activation as signaling by 
TLR2, TLR4, TLR5, and TLR9 is elevated in p85a defi- 
cient mice [36,37]. Then, it appears that PI3K is an im- 
portant TLR activation component that affects signaling 
in different ways depending on cell type and readout. In 
this work we demonstrated that stimulation of BIE cells 
with heat-killed ETEC activated PI3K pathway, indicat- 
ing that PI3K is positively involved in TLR4 signaling in 
BIE cells. Moreover, we demonstrated that bifidobacteria 
able to reduce activation PI3K pathway were the strains 
with the highest anti-inflammatory activity (Figure 7). 
4) The anti-inflammatory effect of bifidobacteria in 
BIE cells is partially dependent on TLR2. In previous 
works evaluating the immunoregulatory activity of im-  
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munobiotics in porcine immune cells and IECs we dem- 
onstrated that the upregulation of some regulatory cyto- 
kines and downregulation of inflammatory mediators 
was dependent of TLR2 activation [13,20]. In this work 
we evaluated this possibility by using anti-TLR2 block- 
ing antibodies. We further demonstrated that the reduc- 
tion of IL-6 induced by bifidobacteria in BIE cells was 
abolished when anti-TLR2 antibodies were used. This is 
in line with other reports demonstrating an important 
regulatory role of TLR2 in the recognition of bifidobac- 
teria which possess immunoinhibitory effect [6,38,39]. It 
is known that TLR2 can induce tolerance against LPS 
that is referred to as heterotolerance or crosstolerance. 
Therefore, it is possible that bifidobacteria could induce 
crosstolerance in BIE cells through their interaction with 
TLR2. In addition, we showed that the reduction of 
MCP-1 levels after challenge of BIE cells was not abol- 
ished when anti-TLR2 antibodies were used. This finding 
indicates that a PRR(s), other than TLR2, may mediate 
the anti-inflammatory effects of bifidobacteria in BIE 
cells. Identification of the unknown receptor or receptors 
is an interesting topic for future investigations. 
5. Conclusion 
We firstly reported in this study that BIE cells can be 
used for the selection of immunoregulatory bifidobacte- 
ria and for studying the mechanisms involved in the pro- 
tective activity of immunobiotics against TLR4-induced 
inflammatory damage. The screening and precise selec- 
tion of bifidobacteria strains that are able to beneficially 
modulate the immune system in the bovine host can pro- 
vide useful information that may be used for the devel- 
opment of new immunologically functional feeds. In addi- 
tion, we have demonstrated in this work that the anti- 
inflammatory effect of bifidobacteria was achieved by a 
complex interaction of multiple TLRs negative regulators 
as well as the inhibition/activation of multiple signaling 
pathways (Figure 7). 
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